BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35675999)

  • 1. Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis.
    Tsukui Y; Kitahara Y; Hasegawa Y; Kobayashi M; Osuka S; Iwase A
    Endocr J; 2022 Aug; 69(8):897-906. PubMed ID: 35675999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
    Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
    Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
    [No Abstract]   [Full Text] [Related]  

  • 4. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK; Oh JY; Lee H; Sung YA
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
    Vural F; Vural B; Kardaş E; Ertürk Coşkun AD; Yildirim İ
    Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
    Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
    Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D; Gronier H; Poncelet E; Robin G; Leroy M; Pigny P; Duhamel A; Catteau-Jonard S
    Hum Reprod; 2011 Nov; 26(11):3123-9. PubMed ID: 21926054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.
    Jacob SL; Field HP; Calder N; Picton HM; Balen AH; Barth JH
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):395-400. PubMed ID: 27805276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
    Piltonen TT; Komsi E; Morin-Papunen LC; Korhonen E; Franks S; Järvelin MR; Arffman RK; Ollila MM
    Eur J Endocrinol; 2023 Jun; 188(6):547-554. PubMed ID: 37294941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome.
    Halder A; Kumar H; Sharma M; Jain M; Kalsi AK; Pandey S
    Indian J Med Res; 2023 Oct; 158(4):397-406. PubMed ID: 37991331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
    Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
    Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.